Green Cross Holdings Preference Shares - Asset Resilience Ratio
Green Cross Holdings Preference Shares (005257) has an Asset Resilience Ratio of 0.50% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Green Cross Holdings Preference Shares working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Green Cross Holdings Preference Shares's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Green Cross Holdings Preference Shares balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Green Cross Holdings Preference Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Green Cross Holdings Preference Shares to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩20.43 Billion | 0.5% |
| Total Liquid Assets | ₩20.43 Billion | 0.50% |
Asset Resilience Insights
- Limited Liquidity: Green Cross Holdings Preference Shares maintains only 0.50% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Green Cross Holdings Preference Shares Industry Peers by Asset Resilience Ratio
Compare Green Cross Holdings Preference Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
CSL Ltd
AU:CSL |
Biotechnology | 0.41% |
|
Vaxcyte Inc
NASDAQ:PCVX |
Biotechnology | 41.54% |
|
Bachem Holding AG
SW:BANB |
Biotechnology | 0.00% |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX |
Biotechnology | 38.51% |
|
Chongqing Zhifei Bio Products
SHE:300122 |
Biotechnology | -0.08% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
Biotechnology | 2.30% |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
Biotechnology | 0.12% |
Annual Asset Resilience Ratio for Green Cross Holdings Preference Shares (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Green Cross Holdings Preference Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.48% | ₩19.63 Billion ≈ $13.30 Million |
₩4.07 Trillion ≈ $2.76 Billion |
+0.30pp |
| 2024-12-31 | 0.19% | ₩6.79 Billion ≈ $4.60 Million |
₩3.67 Trillion ≈ $2.49 Billion |
-0.39pp |
| 2023-12-31 | 0.58% | ₩21.57 Billion ≈ $14.62 Million |
₩3.74 Trillion ≈ $2.53 Billion |
-0.30pp |
| 2022-12-31 | 0.87% | ₩31.34 Billion ≈ $21.24 Million |
₩3.59 Trillion ≈ $2.43 Billion |
-0.92pp |
| 2021-12-31 | 1.80% | ₩62.83 Billion ≈ $42.58 Million |
₩3.50 Trillion ≈ $2.37 Billion |
-0.13pp |
| 2020-12-31 | 1.92% | ₩62.35 Billion ≈ $42.25 Million |
₩3.24 Trillion ≈ $2.20 Billion |
+0.28pp |
| 2019-12-31 | 1.64% | ₩45.49 Billion ≈ $30.82 Million |
₩2.77 Trillion ≈ $1.88 Billion |
+0.86pp |
| 2018-12-31 | 0.78% | ₩20.53 Billion ≈ $13.91 Million |
₩2.63 Trillion ≈ $1.78 Billion |
+0.66pp |
| 2017-12-31 | 0.12% | ₩3.07 Billion ≈ $2.08 Million |
₩2.56 Trillion ≈ $1.74 Billion |
-3.81pp |
| 2016-12-31 | 3.93% | ₩88.35 Billion ≈ $59.87 Million |
₩2.25 Trillion ≈ $1.52 Billion |
+0.30pp |
| 2015-12-31 | 3.63% | ₩74.66 Billion ≈ $50.59 Million |
₩2.06 Trillion ≈ $1.40 Billion |
-0.28pp |
| 2014-12-31 | 3.90% | ₩69.89 Billion ≈ $47.37 Million |
₩1.79 Trillion ≈ $1.21 Billion |
+1.72pp |
| 2013-12-31 | 2.19% | ₩35.51 Billion ≈ $24.06 Million |
₩1.62 Trillion ≈ $1.10 Billion |
-- |
About Green Cross Holdings Preference Shares
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more